Press Release|Articles|November 12, 2024

Camber Pharmaceuticals Launches Generic Xeloda®

Key Takeaways

Capecitabine Tablets, USP, are now part of Camber Pharmaceuticals' product offerings, targeting multiple cancer types.
Indications include colorectal, breast, gastric, esophageal, gastroesophageal junction, and pancreatic cancers.
Available strengths are 150 mg and 500 mg, with packaging in 60-count and 120-count bottles.

Camber Pharmaceuticals is excited to announce the addition of Capecitabine Tablets, USP, to our product portfolio. Capecitabine is a nucleoside metabolic inhibitor indicated for the treatment of several cancers, including:

Colorectal Cancer
Breast Cancer
Gastric, Esophageal, or Gastroesophageal Junction Cancer
Pancreatic Cancer

For more information about these indications, please visit our website: www.camberpharma.com/capecitabine. Capecitabine Tablets, USP are available in the following strengths and packaging options:

150 mg – 60 count bottles
500 mg – 60 count and 120 count bottles

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Latest CME

Virtual Event

Diabetes Day of Education 2026

Thursday, May 14, 2026

Webinar Registration

Cool Solutions: Non-Hormonal Advances in Vasomotor Symptoms Treatment

Wednesday, May 27, 2026 | 1:00 PM & 8:00 PM EDT

Online Article

Advancing Stroke Prevention: The Pharmacist’s Role in Implementing the 2024 Guidelines

1.0 Credit / Cardiology

Camber Pharmaceuticals Launches Generic Xeloda®

Key Takeaways

Newsletter

Related Content

Camber Launches Abacavir and Lamivudine Tablets, USP

Camber Launches Colchicine Capsules

Camber Pharmaceuticals Adds Metformin Hydrochloride Oral Solution to Growing Portfolio

Camber Launches Prucalopride Tablets

Camber Announces Addition of Chlorpromazine HCl Injection, USP

Latest CME

Diabetes Day of Education 2026

Cool Solutions: Non-Hormonal Advances in Vasomotor Symptoms Treatment

Advancing Stroke Prevention: The Pharmacist’s Role in Implementing the 2024 Guidelines

Managing Iron Replacement Therapies for Patients With Inflammatory Bowel Disease

Navigating the Complexities of Hormone Receptor–Positive/HER2-Negative Metastatic Breast Cancer in Older Adults: Personalized Treatments for a Vulnerable Population

Immunology Specialty Pharmacy Day of Education 2026

Respiratory Syncytial Virus Disease Prevention in Adults: The Pharmacist’s Role in Improving Vaccine Uptake

Not All Bispecifics Are Equal: Mechanism-Based Approaches to Selection and Management in Oncology Practice

Enhancing Patient Outcomes in Metastatic Colorectal Cancer: Equipping Community, Veterans Affairs, and Oncology Pharmacists to Navigate Care in the Third-Line Setting and Beyond

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

Cardiology Day of Education 2026

Targeting Genomic Drivers to Optimize ROS1-Directed Therapy in NSCLC

Oncology Pharmacists Connect 2026

From Molecule to Medication: Integrating Menin Inhibitors in AML Practice

The Educated Pharmacist: Using Patient Insights to Personalize Insulin Therapy and Prevent Clinical Inertia

Breaking Barriers in Asthma Care: Exploring the Role of Type 2 Inflammation and Biologic Therapies

Shaping the Future of Generalized Myasthenia Gravis Management: A Focus on Novel Treatment Approaches

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

The Oncology Pharmacist's Role in Managing Small Molecule Inhibitor Use in Chronic Lymphocytic Leukemia to Enhance Patient-Centered Care

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians (Pharmacy Technician Credit)

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

From Guidelines to Action: Implementing Pneumococcal Vaccine ACIP Recommendations in Long-Term Care Settings

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer

Shaping the Future of Renal Cell Carcinoma: A Case-Based Exploration of Emerging Treatment and Improved Patient Outcomes

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

Improving the Care of Persons Living With Diabetes Using CGM Devices

Demystifying CGM: Addressing Frequently Asked Questions and Key Insights

Demystifying CGM: Addressing Frequently Asked Questions and Key Insights (Pharmacy Technician Credit)

Understanding Type 2 Inflammation and Its Role Across Various Immune-Related Diseases

Directions in Pharmacy 2026

From Evidence to Access: Integrating SGLT2 Inhibitors Across the Cardiorenal-Metabolic Continuum

Payment for Pharmacist Services: 2025 Update

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

Protecting Against Meningococcal Disease: Updates on Vaccines, Guidelines, and Pharmacist Best Practices

Influenza Immunization in Older Adults: Enhanced Vaccines and Best Practices for Long-Term Care Pharmacists

Innovations in Retinal Therapies: A Managed Care Perspective on Anti-VEGF Advancements

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

Treating MASH in 2026: Guideline-Directed Care and Emerging Therapeutic Strategies

Diabetes Day of Education 2026

Bridging Gaps in Meningococcal Protection: Pharmacist-Led Approaches to Vaccination and Public Health Equity

Evolving Care: Treating Demodex Blepharitis for Pharmacists

Navigating the Metabolic MASH-Up: Integrating Screening Modalities and Specialty Pharmacotherapy in MASLD Care

Implementing Pharmacist-Led Strategies to Support Comprehensive MASH Management

The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care

Cardiology Day of Education 2026

A Deep Dive Into CGM Data

Advancements With CGM Integrations: Insulin Pumps, Connected Pens, and Ketone Monitoring

Improving the Care of Persons Living With Diabetes Using CGM Devices (Pharmacy Technician Credit)

Advancements With CGM Integrations: Insulin Pumps, Connected Pens, and Ketone Monitoring (Pharmacy Technician Credit)

Continuous Glucose Monitoring: What's New in 2025?

A Deep Dive Into CGM Data (Pharmacy Technician Credit)

Continuous Glucose Monitoring: What's New in 2025? (Pharmacy Technician)